Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients
Clinical trial NCT05947825 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05947825
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.